cyanides has been researched along with Thrombopenia in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Berglund, A; Larsson, R; Nygren, P; von Heideman, A | 1 |
Ahlgren, J; Bergh, J; Hovstadius, P; Jonsson, E; Karlsson, MO; Kissmeyer, AM; Krasilnikoff, K; Larsson, R; Lönnebo, A; Skov, T | 1 |
2 trial(s) available for cyanides and Thrombopenia
Article | Year |
---|---|
Safety and efficacy of NAD depleting cancer drugs: results of a phase I clinical trial of CHS 828 and overview of published data.
Topics: Acrylamides; Aged; Clinical Trials, Phase I as Topic; Cyanides; Dose-Response Relationship, Drug; Drug Administration Schedule; Fatigue; Female; Guanidines; Humans; Male; Meta-Analysis as Topic; Middle Aged; NAD; Nausea; Neoplasms; Nicotinamide Phosphoribosyltransferase; Piperidines; Thrombocytopenia; Treatment Outcome; Vomiting | 2010 |
A Phase I study of CHS 828 in patients with solid tumor malignancy.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Cyanides; Female; Gastrointestinal Diseases; Guanidines; Humans; Lymphopenia; Male; Middle Aged; Neoplasms; Research Design; Thrombocytopenia; Treatment Failure | 2002 |